Quest to Distribute Guardant Colon Cancer Blood Test

Quest to distribute Guardant colon cancer blood test

Guardant Health Co-CEO AmirAli Talasaz also unveiled plans to launch the Shield test for multi-cancer detection in October.

Quest Diagnostics and Guardant Health collaborate for blood-based cancer screening

Guardant Health, Inc., a leading precision oncology company, and Quest Diagnostics, a leader in diagnostic information services with headquarters in Secaucus, announced a broad strategic collaboration to make Guardant’s Shield blood-based screening test available to physicians and patients served by Quest in the United States. Shield is the first and only blood test to receive full FDA approval as a primary screening option for colorectal cancer…